TABLE 6.
Type of model | Treatment, dose and duration | Findings | References |
---|---|---|---|
5/6 nephrectomy rats-induced chronic kidney disease | Post-treatment 60 mg/kg for 8 weeks | ↑ cardiac mitochondrial proteins (ATP synthase β, Porin 1) | Suematsu et al. (2018) |
Chemogenetic rats model of persistent cardiac redox stress | Post-treatment 68 mg/kg orally for 4 weeks | ↑ isocitrate dehydrogenase 2 expression | Sorrentino et al. (2019) |
↓ caspase 3 | |||
Doxorubicin-induced dilated cardiomyopathy in rats | Post-treatment 30 mg/kg/day/orally for 47 days | ↓ cytosolic cytochrome C expression, | Yeh et al. (2021a) |
↓ cyclophilin-D expression | |||
↓ Drp1 expression | |||
↓ Mfn2 expression | |||
↓ electron transport chain complex subunits (I, II, III, and V) expression | |||
↓ mitochondrial Bax expression | |||
↓ cleaved caspase 3 expression | |||
↓ cleaved caspase 9 expression | |||
↓ percentage early and late apoptosis cells | |||
H2O2-induced cell apoptosis in H9C2 cells | Pretreatment 12.5 μM | ↑ mitochondrial-membrane potential, | Yeh et al. (2021b) |
↓ mitochondrial damage | |||
↓ p-Drp1 expression | |||
↓ Mfn2 expression | |||
Cardiorenal syndrome rats fed with high-protein diet | Post-treatment 100 mg/kg/day, orally for 28 days | ↑ mitochondrial cytochrome C expression | Yeh et al. (2021b) |
↓ cytosolic cytochrome C expression | |||
↓ cyclophilin-D expression | |||
↓ DRP1 expression | |||
↓ Mfn2 expression | |||
↓ PGC-1α expression | |||
↑ electron transport chain complex subunits (I,II, III, and V) expression | |||
↓ mitochondrial Bax protein expression | |||
↓ cleaved caspase 3 protein expression | |||
↓ cleaved Poly ADP-ribose polymerase | |||
↓ apoptosis signal-regulating kinase I | |||
↓ p-MMK4, ↓ p-MMK7, ↓ p-ERK, ↓ p-c-Jun | |||
Simultaneous heart and kidney I/R-induced injury in rats | Post-treatment 10 mg/kg, orally at 30 min/followed by days 1–5 twice daily | ↑ mitochondrial cytochrome C expression | Sung et al. (2022) |
↓ cytosolic cytochrome C expression | |||
↓ mitochondrial Bax expression | |||
↓ cleaved caspase 3 expression | |||
↓ cleaved Poly ADP-ribose polymerase expression | |||
Doxorubicin-induced cardiotoxicity in mice | Concurrent treatment 80 mg/kg orally for 9 days | ↓ caspase 3 | Dindaş et al. (2021) |
ox-LDL-induced inflammation and apoptosis in HUVECs | Pretreatment 10–4 μM | ↓ apoptosis rate (%) | Bai et al. (2021) |
↓ cleaved caspase-3/caspase-3 expression | |||
↓ Bax expression | |||
↑ Bcl-2 expression | |||
High-fat diet and streptozotocin induced-diabetic cardiomyopathy in rats | Post-treatment 68 mg/kg/day, gastric gavage for 8 weeks | ↓ cleaved caspase-3 protein and mRNA expression | Belali et al. (2022) |
↓ Bax protein expression | |||
↑ Bcl-2 protein expression | |||
↓ Bax/Bcl-2 mRNA ratio | |||
Doxorubicin-induced cardiotoxicity in rats | Concurrent treatment 60 mg/kg/day for 6 weeks | ↓ apoptosis in the myocardium | Kim et al. (2022) |
↓ Bax protein expression | |||
↓ caspase 3 protein expression |
ATP, adenosine triphosphate; Bcl-2/Bax; B cell lymphoma 2/Bcl-2-associated X ratio; Drp1, dynamin‐related protein one; HUVECs, human umbilical vein endothelial cells; I/R, ischemia reperfusion; p-ERK, phosphorylated extracellular signal-regulated kinase; p-c-Jun, phosphorylated c-Jun; PGC-1α, peroxisome proliferator-activated receptor coactivator-1α; mfn2, mitofusin two; p-MMK4, phosphorylated mitogen-activated protein kinase kinase four; MMK7, phosphorylated mitogen-activated protein kinase kinase seven; ox-LDL, oxidized low-density lipoprotein; ↓, decrease; ↑, increase.